3.5.1 Clinical phenotype
During the acute phase of the disease, patients with viral reactivation
were more likely to have kidney involvement 22/39 (56%) as compared to
19/54 (35%) non-reactivators (OR, 2.4; 95% CI, 1.0-5.5; p=0.04) (Table
3). There were no significant differences between fever, blood, liver,
lungs, heart or pancreas involvement.